Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2556 of 5804
-
Online course lifts caregiver mood in just 30 days
Symptom relief CompletedThe goal of this study is to learn if a new online training program is helpful to dementia family caregivers. This online program is fully computerized and supports 24/7 access from any location. The main questions it aims to answer are: * Does the training program improves the …
Phase: PHASE2 • Sponsor: Education University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Music before brain surgery: a new tune for stress relief?
Symptom relief Recruiting nowThe study plans to enroll a total of 132 patients. The goal of this study is to measure pre-and post-music intervention changes in patients' vital signs, serum- and plasma-level biomarkers by broad-spectrum proteomics analysis, metabolic analysis, and perceived pain, anxiety, and…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New drug cenobamate tested in real life for stubborn seizures
Disease control Recruiting nowAim of the study is to better characterize the clinical profile of adjunctive cenobamate by collecting data from the current standard clinical practice in France, Germany, and Spain, to describe the real-world clinical response among adult patients affected by focal epilepsy not …
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated Jun 26, 2026 19:03 UTC
-
New hope for tough myeloma: first human trial of JNJ-87562761 begins
Disease control OngoingThe purpose of this study is to determine the recommended phase 2 dose(s) (RP2D\[s\]) of JNJ-87562761 in Part 1 (dose escalation), and to determine the safety and tolerability at RP2D in Part 2 (dose expansion) in participants with multiple myeloma (MM) whose disease has come bac…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Testosterone therapy shows promise for Hard-to-Treat prostate cancer
Disease control Recruiting nowThis phase I trial tests the change in androgen receptor sensitivity, side effects and effectiveness of bipolar androgen therapy, using testosterone, in patients with castration resistant prostate cancer that has spread to other places is the body (metastatic). Bipolar androgen t…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a vitamin B3 pill help fight Alzheimer's? new study investigates
Knowledge-focused Recruiting nowIncreased dietary intake of niacin is correlated with reduced risk of Alzheimer's Disease and age-associated cognitive decline. The goal of this study is to collect data on the penetration of commercially available, FDA approved, extended-release niacin into the spinal fluid. One…
Phase: PHASE1, PHASE2 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New MRI scans reveal hidden lung harm from vaping
Knowledge-focused Recruiting nowA two-center, longitudinal assessment of 40 electronic cigarette users and 40 healthy controls at the initial visit and a follow-up visit 12 months later. This study will determine the impact of electronic cigarette use on pulmonary gas exchange capacity and then corroborate the …
Phase: PHASE2, PHASE3 • Sponsor: Y. Michael Shim, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Magnetic helmet shows promise for long COVID brain fog in small study
Symptom relief CompletedThe purpose of this study is to assess the feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to PASC, and to collect data on safety and efficacy to inform the design of larger clinical studies. A prospective randomized controlled study of 30 p…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can weight loss drugs help endometrial cancer patients during chemo?
Symptom relief Recruiting nowThe researchers are doing this study is to find out whether tirzepatide and semaglutide are practical (feasible) for weight management and blood sugar control for endometrial cancer patients undergoing chemotherapy. The researchers will also look at participants' experience with …
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New study aims to cut arthritis flares by tailoring drug tapering
Disease control Recruiting nowRheumatoid arthritis (RA) is the most common inflammatory joint disorder. Since twenty year and the use of synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and biological (b)DMARD, remission can be reached. When remission is obtained, the physician has no recommendatio…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
AI home coach helps kids master tricky 'R' sounds
Symptom relief Recruiting nowSpeech Sound Disorder (SSD) affects a significant portion of school-aged children, leading to social and emotional challenges that can persist into adolescence and adulthood. The number of productions necessary for a remediated speech sound to generalize to connected speech is ch…
Phase: PHASE2 • Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New Three-Drug cocktail targets untreated leukemia in early trial
Disease control TerminatedThis phase I trial tests safety, side effects and best dose of iadademstat with azacitidine and venetoclax for the treatment of patients with acute myeloid leukemia (AML) who have not received treatment (treatment naive). Chemotherapy drugs, such as iadademstat and azacitidine wo…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a spinal cord device ease stubborn leg pain in diabetes and PAD?
Symptom relief Recruiting nowPeripheral arterial disease (PAD) affects over 230 million adults worldwide and is a highly morbid, costly, and disabling condition. Ischemic leg pain drives disability in PAD patients and results from oxygen supply-demand mismatch, autonomic dysfunction, and muscle breakdown. Th…
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Text therapy shows promise for anxious young adults
Symptom relief CompletedThe purpose of the proposed study is to test the feasibility and efficacy of a "anxiety-focused" text-delivered counseling program to reduce anxiety symptoms among young adults (18-25) with elevated anxiety symptoms. We are primarily interested in whether the intervention will re…
Phase: NA • Sponsor: The University of Tennessee, Knoxville • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New TB vaccine put to the test in unique aerosol challenge study
Knowledge-focused OngoingThe purpose of this study is to: 1. Demonstrate the safety of a novel TB vaccine (ID93/GLA-SE) when given to both BCG-vaccinated and BCG-naïve volunteers. 2. Provide preliminary immunogenicity data of this novel TB vaccine (ID93/GLA-SE). This clinical trial will apply an aeroso…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New study tests simple tools to boost COVID-19 shots in minority communities with arthritis
Knowledge-focused Recruiting nowThe overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to keep cancer patients on treatment by spotting side effects sooner
Symptom relief Recruiting nowTo evaluate the rate of therapy discontinuation due to toxicity (side effects) among participants with cancer using ApricityCare. Investigators want to learn if identification of early clinical signs of irAEs with timely treatment can prevent severity progression and reduce trea…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New ointment shows promise for eczema sufferers
Symptom relief CompletedThe goal of this clinical trial is to learn if CGB-500 works to treat atopic dermatitis in participants ages 12 and older. The goal is also to learn about the safety of CGB-500. The main questions it aims to answer are: Does CGB-500 improve atopic dermatitis by decreasing the ar…
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New pill may boost botox for stubborn neck spasms
Symptom relief Recruiting nowThe most common form of idiopathic dystonia is adult-onset cervical dystonia (CD), a focal form of dystonia affecting the muscles of the neck. CD is often associated with pain and limited range of motion, and frequently leads to reduced quality of life and disability. Effective l…
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Blood test may speed up deadly fungal infection diagnosis
Diagnosis CompletedInvasive fungal infections (IFI) are a major concern for immunocompromised or vulnerable patients. Associated mortality is significant and depends on the timeliness of diagnostic and therapeutic management. Consequently, biomarkers play a key role in therapeutic strategies compar…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC